Status: open
Elixir Cosmetics (Babe lash and brow serums)
Defendant: Elixir Cosmetics
Elixir Cosmetics has agreed to pay $2.3 million to settle allegations that the company failed to disclose that its Babe Lash Essential Lash Serum, Babe Lash Eyelash Serum, Babe Amplifying Brow Serum and Babe Brow Serum contain Isopropyl Cloprostenate, which poses undisclosed risks of adverse reactions. If you purchased any of these products between June 1, 2019, and Jan. 19, 2024, you may be eligible for payment.